STE - STERIS plc
| Previous Close | 123.25 |
| Open | 123.65 |
| Bid | 125.71 x 800 |
| Ask | 125.74 x 2900 |
| Day's Range | 123.65 - 126.24 |
| 52 Week Range | 93.50 - 129.87 |
| Volume | 408,939 |
| Avg. Volume | 411,529 |
| Market Cap | 10.634B |
| Beta (3Y Monthly) | 0.83 |
| PE Ratio (TTM) | 40.04 |
| EPS (TTM) | 3.14 |
| Earnings Date | May 7, 2019 - May 13, 2019 |
| Forward Dividend & Yield | 1.36 (1.06%) |
| Ex-Dividend Date | 2019-02-26 |
| 1y Target Est | 139.60 |
- Simply Wall St.•14 days ago
Are STERIS plc (NYSE:STE) Shareholders Getting A Good Deal?
Two important questions to ask before you buy STERIS plc (NYSE:STE) is, how it makes money and how it spends its cash. After investment, what’s left over is what belongs to you, the investor. This also determines how much the stock...
- Markit•15 days ago
See what the IHS Markit Score report has to say about Steris plc.
Steris plc NYSE:STEView full report here! Summary * ETFs holding this stock are seeing positive inflows * Bearish sentiment is low * Economic output in this company's sector is expanding Bearish sentimentShort interest | PositiveShort interest is low for STE with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flowETF/Index ownership | PositiveETF activity is positive. Over the last month, ETFs holding STE are favorable with net inflows of $72.05 billion. This was the highest net inflow seen over the last one-year.Error parsing the SmartText Economic sentimentPMI by IHS Markit | PositiveAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is strong relative to the trend shown over the past year, and is accelerating. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
- Insider Monkey•15 days ago
Here’s What Hedge Funds Think About Steris Plc (STE)
World-class money managers like Ken Griffin and Barry Rosenstein only invest their wealthy clients' money after undertaking a rigorous examination of any potential stock. They are particularly successful in this regard when it comes to small-cap stocks, which their peerless research gives them a big information advantage on when it comes to judging their worth. […]
- Thomson Reuters StreetEvents•19 days ago
Edited Transcript of STE earnings conference call or presentation 12-Feb-19 3:00pm GMT
Q3 2019 STERIS plc Earnings Call
- Markit•29 days ago
See what the IHS Markit Score report has to say about Steris PLC.
Steris PLC NYSE:STEView full report here! Summary * Bearish sentiment is low Bearish sentimentShort interest | PositiveShort interest is low for STE with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flowETF/Index ownership | NeutralETF activity is neutral. ETFs that hold STE had net inflows of $3.84 billion over the last one-month. While these are not among the highest inflows of the last year, the rate of inflow is increasing. Economic sentimentPMI by IHS Markit | NeutralAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
- Simply Wall St.•last month
These Fundamentals Make STERIS plc (NYSE:STE) Truly Worth Looking At
Want to participate in a research study? Help shape the future of investing tools and earn a $60 gift card! STERIS plc (NYSE:STE) is a stock with outstanding fundamental characteristics.Read More...
- GuruFocus.com•last month
Steris Plc (STE) President & CEO Walter M Rosebrough Jr Sold $6.3 million of Shares
President & CEO of Steris Plc (NYSE:STE) Walter M Rosebrough Jr sold 50,000 shares of STE on 03/21/2019 at an average price of $125 a share.
- Zacks•last month
STERIS (STE) Margin Pressure Hurts, Strategic Growth High
Mounting operating expenses are weighing on the bottom line of STERIS (STE).
- Zacks•last month
Why Is Steris (STE) Up 1.2% Since Last Earnings Report?
Steris (STE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- Simply Wall St.•2 months ago
Is STERIS plc (NYSE:STE) A Financially Sound Company?
Investors pursuing a solid, dependable stock investment can often be led to STERIS plc (NYSE:STE), a large-cap worth US$10b. One reason being its ‘too big to fail’ aura which givesRead More...
- GlobeNewswire•2 months ago
STERIS to Participate in the Raymond James Institutional Investor Conference
DERBY, U.K. - February 19, 2019 - STERIS plc (STE) ("STERIS" or the "Company") announced that it will participate in the Raymond James Institutional Investor Conference on Monday, March 4, 2019. Michael J. Tokich, STERIS`s Senior Vice President and Chief Financial Officer will present at 8:40 a.m. Eastern Time. A simultaneous webcast and replay of the Company`s presentation will be available on STERIS`s investor relations website at www.steris-ir.com. STERIS`s mission is to help our Customers create a healthier and safer world by providing innovative healthcare and life science product and service solutions around the globe.
- Zacks•2 months ago
STERIS (STE) Q3 Earnings In Line, Revenues Beat Estimates
STERIS (STE) continues to gain from strength in all business segments in Q3.
Motley Fool•2 months agoSteris Corp (STE) Q3 2019 Earnings Conference Call Transcript
STE earnings call for the period ending December 31, 2018.
- Zacks•2 months ago
Steris (STE) Matches Q3 Earnings Estimates
Steris (STE) delivered earnings and revenue surprises of 0.00% and 1.21%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
- Associated Press•2 months ago
Steris: Fiscal 3Q Earnings Snapshot
On a per-share basis, the Derby, Britain-based company said it had profit of 56 cents. Earnings, adjusted for non-recurring costs, came to $1.26 per share. The results met Wall Street expectations. The ...
- GlobeNewswire•2 months ago
STERIS Announces Financial Results for Fiscal 2019 Third Quarter
DERBY, U.K. - (February 11, 2019) - STERIS plc (STE) ("STERIS" or the "Company") today announced financial results for its fiscal 2019 third quarter ended December 31, 2018. Revenue as reported for the quarter increased 5% to $696.2 million compared with $661.9 million in the third quarter of fiscal 2018, with growth across all segments. Constant currency organic revenue (see Non-GAAP Financial Measures) growth was 7% for the third quarter of fiscal 2019.
- Zacks•3 months ago
Steris (STE) Reports Next Week: Wall Street Expects Earnings Growth
Steris (STE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks•3 months ago
Steris (STE) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Steris (STE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- GlobeNewswire•3 months ago
STERIS to Announce Fiscal 2019 Third Quarter Financial Results on February 12, 2019
DERBY, U.K. - January 29, 2019- STERIS plc (NYSE: STE) ("STERIS" or the "Company") announced today that it will host a conference call to discuss its fiscal 2019 third quarter financial ...
- GlobeNewswire•3 months ago
Report: Developing Opportunities within Macy's, Leggett & Platt, Tyler Technologies, BioScrip, DXC Technology, and STERIS plc — Future Expectations, Projections Moving into 2019
NEW YORK, Jan. 22, 2019 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.
- Zacks•4 months ago
Here's Why You Should Invest in STERIS (STE) Stock Right Now
With the acquisition of U.K.-based outsourced sterilization services provider Synergy Health, STERIS (STE) has become the global leader in infection prevention and sterilization.
- GlobeNewswire•4 months ago
STERIS to Present at the J.P. Morgan Healthcare Conference
DERBY, U.K. - December 18, 2018 - STERIS plc (STE) ("STERIS" or the "Company") announced that it will participate in the J.P. Morgan Healthcare Conference on Monday, January 7, 2019. Walt Rosebrough, STERIS`s President and CEO, will present at 3:00 p.m. Pacific Time. A simultaneous webcast and replay of the Company`s presentation will be available on STERIS`s investor relations website at www.steris-ir.com. STERIS`s mission is to help our Customers create a healthier and safer world by providing innovative healthcare and life science product and service solutions around the globe.
